The drug Zelnorm, manufactured by Novatis, was taken of the market in March because of a high risk of heart attacks, stroke, and chest pain. But now the FDA is allowing the irritable bowel syndrome drug to become available again, but only for a restricted access program. Zelnorm will remain off the market for the general public.The program is for women in the US under 55 years of age who...